Financials
Income statement
Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
---|---|---|---|---|
Total reported revenue | 1.5B | 1.6B | 1.5B | 1.6B |
Cost of revenue | 1.1B | 1.3B | 1.2B | 1.2B |
Gross profit | 327M | 322M | 305M | 349M |
Operating expense | ||||
Research & development | 24M | 29M | 22M | 27M |
Selling general and admin | 281M | 290M | 275M | 289M |
Other operating expenses | 147M | 42M | -36M | 34M |
Operating income | -29M | -23M | 55M | 24M |
Non operating interest income | ||||
Income | 1M | 2M | 2M | 1M |
Expense | 10M | 12M | 40M | 13M |
Other income expense | — | — | — | — |
Pretax income | -55M | -61M | -68M | 2M |
Tax provision | -10M | -4M | -4M | 0 |
Net income | -45M | -57M | -64M | 2M |
Basic EPS | -0.5 | -0.7 | — | 0.0 |
Diluted EPS | -0.5 | -0.7 | — | 0.0 |
Basic average shares | 86.3M | 86.3M | — | 86.3M |
Diluted average shares | 86.3M | 86.3M | — | 86.3M |
EBITDA | 172M | 86M | 118M | 154M |
Net income from continuing op. | -55M | -61M | -68M | 2M |
Minority interests | 0 | 0 | 0 | -1M |
Preferred stock dividends | 0 | 0 | 0 | 0 |